Related Experiment Videos
Inpatient treatment of unstable angina: clinical perspective and sequential management
Insights
Coronary artery spasm is key in ischemic heart disease. Calcium-channel blockers like nifedipine effectively treat unstable angina, offering a management approach for patients with this condition.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coronary artery spasm and increased tone are increasingly recognized in ischemic heart disease.
- Spasm can occur with or without significant atherosclerosis.
- Most patients with angina have underlying obstructive coronary artery disease.
Purpose of the Study:
- To review the role of calcium-channel blockers in treating angina.
- To focus on the uses and limitations of nifedipine in unstable angina.
- To provide a management strategy for patients with unstable angina.
Main Methods:
- Review of current literature on coronary artery spasm and calcium-channel blockers.
- Focus on clinical data regarding nifedipine efficacy and safety.
- Development of a sequential management approach for unstable angina.
Main Results:
- Calcium-channel blockers are highly effective for stable and unstable angina.
- Nifedipine demonstrates significant utility in managing unstable angina.
- A structured approach to management is beneficial for these patients.
Conclusions:
- Coronary artery spasm is a critical factor in ischemic heart syndromes.
- Nifedipine is a valuable therapeutic option for unstable angina.
- A sequential management plan optimizes patient outcomes.
Abstract:
In the last decade, increasing information has become available to the effect that an increase in coronary artery tone and coronary artery spasm play an important role in patients with various ischemic heart disease syndromes. Coronary spasm may be superimposed on a coronary vessel already severely obstructed by atherosclerosis. Conversely, spasm may occur in an artery that is only minimally involved with atherosclerosis. The majority of patients studied in the United States with both stable and unstable angina pectoris have underlying severe organic obstructive coronary artery disease. There has now emerged a considerable amount of information from several centers showing that the calcium-channel blockers or calcium-flux antagonists are highly effective in the treatment of stable and unstable angina pectoris. This report focuses on the uses and limitations of one of these agents, nifedipine, in patients with unstable angina and provides a sequential approach to their management.